−21.293BRL
−1.04 BBRL
1.21 BBRL
117.65 M
About Arrowhead Pharmaceuticals, Inc.
Sector
Industry
CEO
Christopher Richard Anzalone
Website
Headquarters
Pasadena
Employees (FY)
525
Founded
1989
ISIN
BRA2RRBDR009
FIGI
BBG014XHR9H9
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
